Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

The findings show that the increased ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study found that a tiny ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...